Convergence Investment Partners’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-814
Closed -$501K – 242
2025
Q1
$501K Buy
+814
New +$463K 0.14% 197
2014
Q4
– Sell
-7,422
Closed -$764K – 370
2014
Q3
$764K Buy
+7,422
New +$752K 0.1% 276
2014
Q2
– Sell
-11,334
Closed -$1.01M – 376
2014
Q1
$1.01M Sell
11,334
-29,186
-72% -$2.38M 0.15% 191
2013
Q4
$3.1M Buy
40,520
+10,760
+36% +$793K 0.5% 51
2013
Q3
$2.13M Buy
+29,760
New +$2.12M 0.45% 79

Other funds holding CHE

Convergence Investment Partners's CHE Position: Q2 2025 in Review

Convergence Investment Partners sold out of Chemed (CHE) in Q2 2025, closing a stake of 814 shares — an estimated $501K sold.

Convergence Investment Partners first reported a position in CHE in Q3 2013 and held it in 5 quarters. The position peaked at $3.1M in Q4 2013. 538 funds tracked by Wall St. Rank hold CHE as of Q2 2025.

  • Convergence Investment Partners reported no remaining Chemed position as of Q2 2025 after selling out during the quarter.
  • Convergence Investment Partners sold 814 Chemed shares in Q2 2025, an estimated $501K.
  • Convergence Investment Partners first reported a position in Chemed in Q3 2013 and held it in 5 quarters.
  • Convergence Investment Partners's Chemed position peaked at $3.1M in Q4 2013.
  • 538 funds tracked by Wall St. Rank held Chemed as of Q2 2025.

Based on Convergence Investment Partners's 13F filing for Q2 2025, filed 1 Aug 2025.